liver cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1)Clinically diagnosed primary or metastatic liver cancers less than 4, and with diameter between 1 to 5 cm. 2) No indication or refusal for surgical resection, radio frequency ablation. 4) ECOG Performance Status 0-2 5) The patients can raise their arms and keep supine position with about 30 minutes. 6) Respiratory movement is more than 10mm. 7) Written informed consent
Exclusion criteria
Exclusion criteria: 1) History of radiation therapy to the site 2) Refractory pleural effusion or ascites 3) Esophageal varies with high risk of bleeding 4) Obviously active interstitial pneumonia or pulmonary fibrosis 5) Severe diabetes or collagen disease 6) Pregnant and lactating females 7) Severe mental disorder to participate in this study 8) Patients who are concluded to be inappropriate to participate in this study by their physicians
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 2-year local control rate | — |
Secondary
| Measure | Time frame |
|---|---|
| overall survival rate, progression free survival rate, local progression free survival rate, adverse event, severe adverse event, treatment accuracy, dose-volume index. | — |
Countries
Japan
Contacts
Kyoto University Department of Radiation Oncology and Image-applied Therapy, Graduate School of Medicine